Dr Kevin Wing


Assistant Professor
of Epidemiology


Keppel Street
United Kingdom

I initially trained as a Biochemist, graduating from Bristol University with a BSc (Hons) in 1998. I subsequently completed an MSc in Information Technology at Glasgow University. I have 10 years experience working on technology and processes relating to the licensing and regulation of medicines. In 2010 I completed the MSc Epidemiology at LSHTM and completed my PhD at LSHTM in October 2015.


Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health


I am co-Course Organiser for the Certificate of Pharmacoepidemiology and Pharmacovigilance (PEPI) and a tutor on the DL Statistical Methods in Epidemiology MSc module (EPM202).


I have a general interest in the use of data collected as part of routine clinical care for studies of epidemiology and pharmacoepidemiology. My current main area of research focuses on how the preparation and analysis of randomised controlled trial-analogous cohorts in non-interventional data can be used to help improve the understanding of drug treatment effects in people who were underrepresented or excluded from trials. This has included a focus on Chronic Obstructive Pulmonary Disease (COPD) drug treatment effects within UK primary and secondary care, and I am also involved in projects utilising similar approaches for studying the treatment effects of cardiovascular drugs.

Other research I am either involved in currently or have worked on recently includes investigation of techniques relating to quantitative bias analysis, improving standards for performing pharmacoepidemiological research, quantification of the risk of serious drug-induced liver injury associated with a range of drug treatments, and studies of Ebola using data collected as part of clinical care during and after the 2013-16 West African outbreak. During the COVID-19 pandemic I have been involved in research using the OpenSAFELY platform, including looking at the effect of household composition on COVID-19 outcomes by ethnicity, the dffering risk of severe outcomes by SARS-CoV-variant and COVID survival and diabetes.



Research Area
Clinical databases
Drug discovery and development
Primary care
Electronic health records
Randomised controlled trials
Genetic epidemiology
Disease and Health Conditions
Eye diseases
Emerging Infectious Disease
Respiratory disease
United Kingdom
Sierra Leone

Selected Publications

Incidence of Lyme disease in the United Kingdom and association with fatigue: A population-based, historical cohort study.
Brellier F; Pujades-Rodriguez M; Powell E; Mudie K; Mattos Lacerda E; Nacul L; Wing K
PloS one
Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England.
Grint DJ; Wing K; Houlihan C; Gibbs HP; Evans SJW; Williamson E; McDonald HI; Bhaskaran K; Evans D; Walker AJ
Clinical infectious diseases
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.
Grint DJ; Wing K; Williamson E; McDonald HI; Bhaskaran K; Evans D; Evans SJ; Walker AJ; Hickman G; Nightingale E
Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
Health technology assessment (Winchester, England)
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials.
Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
The European respiratory journal
Improving health information systems during an emergency: lessons and recommendations from an Ebola treatment centre in Sierra Leone.
Oza S; Wing K; Sesay AA; Boufkhed S; Houlihan C; Vandi L; Sebba SC; McGowan CR; Cummings R; Checchi F
Development of a Pediatric Ebola Predictive Score, Sierra Leone1.
Fitzgerald F; Wing K; Naveed A; Gbessay M; Ross JCG; Checchi F; Youkee D; Jalloh MB; Baion DE; Mustapha A
Emerging infectious diseases
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).
Langan SM; Schmidt SA; Wing K; Ehrenstein V; Nicholls SG; Filion KB; Klungel O; Petersen I; Sorensen HT; Dixon WG
BMJ (Clinical research ed.)
Surviving Ebola: A historical cohort study of Ebola mortality and survival in Sierra Leone 2014-2015.
Wing K; Oza S; Houlihan C; Glynn JR; Irvine S; Warrell CE; Simpson AJH; Boufkhed S; Sesay A; Vandi L
PloS one
Risk in the \"Red Zone\": Outcomes for Children Admitted to Ebola Holding Units in Sierra Leone Without Ebola Virus Disease.
Fitzgerald F; Wing K; Naveed A; Gbessay M; Ross JCG; Checchi F; Youkee D; Jalloh MB; Baion D; Mustapha A
Clinical infectious diseases
Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola Infections.
Oza S; Sesay AA; Russell NJ; Wing K; Boufkhed S; Vandi L; Sebba SC; Cummings R; Checchi F
Emerging infectious diseases
Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.
Wing K; Bhaskaran K; Pealing L; Root A; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
The Journal of antimicrobial chemotherapy
Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury.
Wing K; Bhaskaran K; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
BMJ open
Development of predictive genetic tests for improving the safety of new medicines: the utilization of routinely collected electronic health records.
Wing K; Douglas I; Bhaskaran K; Klungel OH; Reynolds RF; Pirmohamed M; Smeeth L; van Staa TP
Drug discovery today
See more Publications